Desbenzyl Donepezil Hydrochloride - CAS 120013-39-0
Catalog: |
BB004697 |
Product Name: |
Desbenzyl Donepezil Hydrochloride |
CAS: |
120013-39-0 |
Synonyms: |
5,6-Dimethoxy-2-[(4-piperidyl)methyl]-1-indanone Hydrochloride; 1H-Inden-1-one, 2,3-dihydro-5,6-dimethoxy-2-(4-piperidinylmethyl)-, hydrochloride (1:1); 1H-Inden-1-one, 2,3-dihydro-5,6-dimethoxy-2-(4-piperidinylmethyl)-, monohydrochloride; 4-[(5,6-Dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride; Donepezil Desbenzyl Impurity |
Related CAS: | 120014-30-4 (free base)
|
IUPAC Name: | 5,6-dimethoxy-2-(piperidin-4-ylmethyl)-2,3-dihydroinden-1-one;hydrochloride |
Description: | Desbenzyl Donepezil Hydrochloride is an impurity of Donepezil, which is a centrally acting reversible acetyl cholinesterase inhibitor for the treatment of moderate to severe Alzheimer's disease. |
Molecular Weight: | 325.83 |
Molecular Formula: | C17H24ClNO3 |
Canonical SMILES: | COC1=C(C=C2C(=C1)CC(C2=O)CC3CCNCC3)OC.Cl |
InChI: | InChI=1S/C17H23NO3.ClH/c1-20-15-9-12-8-13(7-11-3-5-18-6-4-11)17(19)14(12)10-16(15)21-2;/h9-11,13,18H,3-8H2,1-2H3;1H |
InChI Key: | WOZXDQQCMZIQEG-UHFFFAOYSA-N |
Melting Point: | 249-250°C (dec.) |
Purity: | ≥95% |
Solubility: | Soluble in Chloroform (Slightly), DMSO (Sparingly), Methanol (Slightly) |
Appearance: | Off-white to pale yellow solid |
Storage: | Store at 2-8°C |
MDL: | MFCD09033179 |
LogP: | 3.57930 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] |
Precautionary Statement: | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
BR-102013030928-A2 | process for the preparation of donepezil hydrochloride forms i and iii; and an intermediate compound thereof | 20131129 |
WO-2015109377-A1 | Process for preparing donepezil hydrochloride forms i and iii; and an intermediate compound thereof | 20131129 |
EP-1654230-A1 | Preparation of intermediates for acetyl cholinesterase inhibitors | 20030701 |
US-2006041140-A1 | Preparation of intermediates for acetyl cholinesterase inhibitors | 20030701 |
US-7446203-B2 | Preparation of intermediates for acetycholinesterase inhibitors | 20030701 |
Complexity: | 367 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 2 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 325.1444713 |
Formal Charge: | 0 |
Heavy Atom Count: | 22 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 325.1444713 |
Rotatable Bond Count: | 4 |
Topological Polar Surface Area: | 47.6 |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
-
[500-49-2]
5-Propylbenzene-1,3-diol
-
[711-38-6]
2,2,2-Trifluoro-4'-methoxyacetophenone
-
[75726-96-4]
2-Bromo-N-isopropylacetamide
-
[1408282-26-7]
8-Fluoro-4,5-dihydro-1H-azepino[5,4,3-CD]indol-6(3H)-one
-
[80935-59-7]
(Benzene-1,3,5-triyl)triacetonitrile
-
[1388152-02-0]
1,2-Cyclopentanediol, 3-amino-5-[(phosphonooxy)methy]-, ammonium salt (1:2), (1R,2S,3R,5R)-
INDUSTRY LEADERS TRUST OUR PRODUCTS